Nanoparticle-mediated gene delivery to tumour neovasculature

A.R. Reynolds, S.M. Moghimi, K. Hodivala-Dilke

Research output: Contribution to journalArticlepeer-review


The αvβ3 integrin is a potential pharmacological target for anti-angiogenic therapy. A recent report describes the use of αvβ3-targeted nanoparticles to deliver a gene to tumour vasculature selectively. This resulted in substantial tumour regression in several experimental mouse tumour models. Hence, this approach has great potential for the treatment of human cancer.
Original languageEnglish
Pages (from-to)2-4
Number of pages3
JournalTrends in molecular medicine
Issue number1
Publication statusPublished - Jan 2003


Dive into the research topics of 'Nanoparticle-mediated gene delivery to tumour neovasculature'. Together they form a unique fingerprint.

Cite this